Ropes & Gray represented Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, in the acquisition of Praha Vaccines a.s., part of the Cyrus Poonawalla Group, in an all cash transaction of approximately $167 million. The acquisition includes a biologics manufacturing facility and associated assets in Bohumil, Czech Republic.
The facility is expected to provide an annual capacity of over 1 billion doses of antigen starting in 2021 for Novavax’ COVID-19 vaccine candidate. It consists of a stable, prefusion protein antigen made using its proprietary nanoparticle technology and adjuvant. The transaction was announced on May 27.
The team was led by mergers & acquisitions partner Tara Fisher (Boston) and included tax partner David Saltzman (Boston), privacy & cybersecurity partner Rohan Massey (London), mergers & acquisitions partner Paul Kinsella (Boston), and real estate partner Jack Creedon (Boston).
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.